Cite
Cerebral Venous Sinus Thrombosis in the U.S. Population, After Adenovirus-Based SARS-CoV-2 Vaccination, and After COVID-19.
MLA
Bikdeli, Behnood, et al. “Cerebral Venous Sinus Thrombosis in the U.S. Population, After Adenovirus-Based SARS-CoV-2 Vaccination, and After COVID-19.” Journal of the American College of Cardiology, vol. 78, no. 4, July 2021, pp. 408–11. EBSCOhost, https://doi.org/10.1016/j.jacc.2021.06.001.
APA
Bikdeli, B., Chatterjee, S., Arora, S., Monreal, M., Jimenez, D., Krumholz, H. M., Goldhaber, S. Z., Elkind, M. S. V., & Piazza, G. (2021). Cerebral Venous Sinus Thrombosis in the U.S. Population, After Adenovirus-Based SARS-CoV-2 Vaccination, and After COVID-19. Journal of the American College of Cardiology, 78(4), 408–411. https://doi.org/10.1016/j.jacc.2021.06.001
Chicago
Bikdeli, Behnood, Saurav Chatterjee, Shilpkumar Arora, Manuel Monreal, David Jimenez, Harlan M Krumholz, Samuel Z Goldhaber, Mitchell S V Elkind, and Gregory Piazza. 2021. “Cerebral Venous Sinus Thrombosis in the U.S. Population, After Adenovirus-Based SARS-CoV-2 Vaccination, and After COVID-19.” Journal of the American College of Cardiology 78 (4): 408–11. doi:10.1016/j.jacc.2021.06.001.